Back
Pliant Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
PLRX
Pliant Therapeutics, Inc.
Last Price:
$1.35
Seasonality Move:
-17.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight buying pressure.
Pliant Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.26 | Buy |
| 20-day SMA: | 1.3 | Buy |
| 50-day SMA: | 1.26 | Buy |
| 200-day SMA: | 1.43 | Sell |
| 8-day EMA: | 1.22 | Buy |
| 20-day EMA: | 0.89 | Buy |
| 50-day EMA: | 0.49 | Buy |
| 200-day EMA: | 0.14 | Buy |
Pliant Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 56.64 | Buy |
| Chaikin Money Flow: | 208641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.25 - 1.35) | Buy |
| Bollinger Bands (100): | (1.17 - 1.47) | Buy |
Pliant Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics, Inc. Stock
Is Pliant Therapeutics, Inc. Stock a Buy?
-
Pliant Therapeutics, Inc. share price is 1.35 while PLRX 8-day simple moving average is 1.26, which is a Buy signal.
-
The stock price of PLRX is 1.35 while Pliant Therapeutics, Inc. 20-day SMA is 1.30, which makes it a Buy.
-
Pliant Therapeutics, Inc. 50-day simple moving average is 1.26 while PLRX share price is 1.35, making it a Buy technically.
-
PLRX stock price is 1.35 and Pliant Therapeutics, Inc. 200-day simple moving average is 1.43, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
32
Pliant Therapeutics, Inc. (PLRX)
is a Sell
Is Pliant Therapeutics, Inc. a Buy or a Sell?
-
Pliant Therapeutics, Inc. stock is rated a SellThe current Pliant Therapeutics, Inc. [PLRX] share price is $1.35. The Score for PLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics, Inc. Stock Info
Market Cap:
85.5M
Price in USD:
1.35
Share Volume:
521.6K
Pliant Therapeutics, Inc. 52-Week Range
52-Week High:
1.95
52-Week Low:
1.09
Sell
32
Pliant Therapeutics, Inc. (PLRX)
is a Sell
Pliant Therapeutics, Inc. Share Price Forecast
-
What is the Pliant Therapeutics, Inc. stock price today?The Pliant Therapeutics, Inc. stock price is 1.35 USD today.
-
Will PLRX stock go up or go down?Pliant Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Pliant Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics, Inc. is overvalued.
Is Pliant Therapeutics, Inc. Stock a Buy?
-
Pliant Therapeutics, Inc. share price is 1.35 while PLRX 8-day exponential moving average is 1.22, which is a Buy signal.
-
The stock price of PLRX is 1.35 while Pliant Therapeutics, Inc. 20-day EMA is 0.89, which makes it a Buy.
-
Pliant Therapeutics, Inc. 50-day exponential moving average is 0.49 while PLRX share price is 1.35, making it a Buy technically.
-
PLRX stock price is 1.35 and Pliant Therapeutics, Inc. 200-day simple moving average is 0.14, creating a Buy signal.
Fundamental Analysis of Pliant Therapeutics, Inc.
Is Pliant Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, an increase this year of $0.89 per share, and an increase next year of $0.32 per share.
Technical Analysis of Pliant Therapeutics, Inc.
Should I short Pliant Therapeutics, Inc. stock?
-
PLRX Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting Pliant Therapeutics, Inc. is a Buy
-
Pliant Therapeutics, Inc. Relative Strength Index (RSI) is 56.64, which suggest Pliant Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Pliant Therapeutics, Inc. is (1.25 - 1.35), which suggest Pliant Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Pliant Therapeutics, Inc. is (1.17 - 1.47), which suggest Pliant Therapeutics, Inc. is a Buy
* Pliant Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.